Hostname: page-component-74656f9884-npj9w Total loading time: 0 Render date: 2026-11-09T23:54:08.854Z Has data issue: false hasContentIssue false

Effect of non-pharmacological interventions on the COVID-19 epidemic in Saudi Arabia

Published online by Cambridge University Press:  29 November 2021

Naif I. AlJohani*
Affiliation:
Harvard T. H. Chan School of Public Health, Boston, MI, USA Consultant at King Faisal Specialist Hospital & Research Centre, Jeddah, Saudi Arabia
Kipkoech Mutai
Affiliation:
Consultant at Stat-Simp Consulting, Eldoret, Kenya
*
Author for correspondence: Naif I. AlJohani, E-mail: naifaljohani@hsph.harvard.edu
Rights & Permissions [Opens in a new window]

Abstract

We quantified the potential impact of different social distancing and self-isolation scenarios on the coronavirus disease 2019 (COVID-19) pandemic trajectory in Saudi Arabia and compared the modelling results to the confirmed epidemic trajectory. Using the susceptible, exposed, infected, quarantined and self-isolated, requiring hospitalisation, recovered/immune individuals, fatalities model, we assessed the impact of a non-pharmacological interventions’ subset. An unmitigated scenario (baseline), mitigation scenarios (25% reduction in social contact/twofold increase in self-isolation) and enhanced mitigation scenarios (50% reduction in social contact/twofold increase in self-isolation) were assessed and compared to the actual epidemic trajectory. For the unmitigated scenario, mitigation scenarios, enhanced mitigation scenarios and actual observed epidemic, the peak daily incidence rates (per 10 000 population) were 77.00, 16.00, 9.00 and 1.14 on days 71, 54, 35 and 136, respectively. The peak fatality rates were 35.00, 13.00, 5.00 and 0.016 on days 150, 125, 60 and 155, respectively. The R0 was 1.15, 1.14, 1.22 and 2.50, respectively. Aggressive implementation of social distancing and self-isolation contributed to the downward trend of the disease. We recommend using extensive models that comprehensively consider the natural history of COVID-19, social and behavioural patterns, age-specific data, actual network topology and population to elucidate the epidemic's magnitude and trajectory.

Information

Type
Original Paper
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
Copyright © The Author(s), 2021. Published by Cambridge University Press
Figure 0

Fig. 1. Non-pharmacological interventions employed by the Saudi Arabian government and their effects on the number of daily confirmed cases.

Figure 1

Fig. 2. Flow diagram of the SEIQHRF model compartments and transition parameters (Appendix A: Table 1 provides additional information on the definitions and sources of the indicated transition parameters). SEIQHRF, susceptible, exposed, infected, quarantined and self-isolated, requiring hospitalisation, recovered/immune individuals, fatalities due to COVID-19.

Figure 2

Table 1. Model parameters description

Figure 3

Fig. 3. Distributions of the durations that individuals spent in each of the key compartments of the model. (a) Distribution of the incubation period, i.e. the period between the exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the onset of symptoms; (b) distribution of duration at which symptomatic (or tested positive), infected and infectious people enter self-isolation; (c) distribution of duration at which people who are infected and symptomatic recover; (d) distribution of duration at which people needing hospitalisation or are hospitalised recover; (e) distribution of duration at which symptomatic (or tested positive), infected and infectious people or self-isolated people enter the state of requiring hospital care; (f) distribution of survival duration of fatalities.

Figure 4

Fig. 4. Trajectory of rates (cases per 10 000) per compartment for the baseline scenario vs. the two non-pharmaceutical intervention scenarios with variable levels of reduced social contact. The mitigation scenario assumes a 25% reduction in social contact through social distancing and a twofold increase in self-isolation rates; the enhanced mitigation scenario assumes a 50% reduction in social contact through social distancing and a twofold increase in self-isolation rates.

Figure 5

Table 2. Comparison of baseline vs. NPI scenarios

Figure 6

Fig. 5. Incidence rates (cases per 10 000) for the baseline (unmitigated) scenario vs. the two non-pharmaceutical intervention scenarios with variable levels of reduced social contact. The mitigation scenario assumed a 25% reduction in social contact through social distancing and a twofold increase in self-isolation rates; the enhanced mitigation scenario assumed a 50% reduction in social contact through social distancing and a twofold increase in self-isolation rates.

Figure 7

Fig. 6. (a) Hospitalisation and (b) fatality rates (cases per 10 000) for the baseline (unmitigated) scenario vs. the two non-pharmaceutical intervention scenarios with variable levels of reduced social contact. The mitigation scenario assumed a 25% reduction in social contact through social distancing and a twofold increase in self-isolation rates; the enhanced mitigation scenario assumed a 50% reduction in social contact through social distancing and a twofold increase in self-isolation rates. The red line in (a) corresponds to the number of available hospital beds in the KSA (27 per 10 000).